Stocktoria
CalciMedica, Inc. CALC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-09-25
CalciMedica, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| R&D expense | $15.2M | $14.5M | $15.9M | $8.3M | $18.9M |
| Operating income | -$23.1M | -$24.2M | -$38.1M | -$14.2M | -$35.9M |
| Income tax | $0 | $0 | $1,000 | $1,000 | — |
| Net income | -$29.6M | -$13.7M | -$34.4M | -$7.8M | -$35.8M |
| EPS (diluted) | $-1.97 | $-1.22 | $-7.66 | $-111.16 | $-1.69 |
| Operating cash flow | -$21.2M | -$21.1M | -$25.7M | -$11.8M | -$31.5M |
| Free cash flow | -$21.2M | -$21.2M | -$25.8M | -$11.8M | -$32.0M |
| Cash & equivalents | $11.5M | $7.9M | $5.5M | $1.3M | $13.4M |
| Total assets | $13.6M | $19.8M | $12.2M | $3.3M | $69.1M |
| Total liabilities | $20.2M | $5.4M | $4.0M | $12.6M | $4.1M |
| Shareholders' equity | -$6.6M | $14.4M | $8.2M | -$71.3M | -$64.0M |
Source: SEC EDGAR filings · CIK 0001534133 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.